Client News
Filter by:
- Jan 10 2023 SAB Biotherapeutics Successfully Concludes IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes
- Jan 9 2023 Genius Brands Premieres “Kidaverse Roblox Rumble” and Accompanying Games Exclusively on Kartoon Channel!
- Jan 9 2023 SAB Biotherapeutics’ CMO Alexandra Kropotova to Deliver Presentation on Next Generation Biologics in Immunology at Biotech Showcase
- Jan 5 2023 Ecolab Schedules Webcast and Conference Call on February 14
- Jan 5 2023 Co-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8
- Jan 5 2023 Genius Brands Expands Kartoon Channel! With Launch on Vizio Smart TVs
- Jan 5 2023 Salarius Pharmaceuticals Announces Issuance of New U.S. Patent for Next-Generation Targeted Protein Degraders
- Jan 5 2023 SAB Biotherapeutics Novel DiversitAb™ Platform Proven to Develop Anti-idiotype Antibodies to Help Treat Autoimmune Diseases
- Jan 5 2023 Galectin Therapeutics Announces the End of Enrollment of NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Liver Cirrhosis Caused by Non-Alcoholic Steatohepatitis
- Jan 5 2023 Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh